18 and older, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Time to CompletionPrimary· 7 days
Completion time for each repetition of Fundamentals of Laparoscopic Surgery (FLS) task 1 in post-test (1 single repetition of the task that was timed after all training was completed)
Group
Value
95% CI
Bilateral M1, Active tDCS
55.3
± 15.4
SMA, Active tDCS
54.5
± 13.1
Sham tDCS
59.5
± 18.3
Number of ErrorsSecondary· 7 days
The number of errors (as defined by FLS) during completion of tasks will be recorded and transitioned into a time addition. This will be collected for every repetition performed during the 6 separate training sessions within a 7-day period. These errors will be defined and retrospective review of recorded video through study completion.
Drops out of view- session 1
Group
Value
95% CI
Bilateral M1, Active tDCS
1.3
± 1.6
SMA, Active tDCS
1.4
± 1.6
Sham tDCS
1.2
± 1.2
Drops out of view- Session 2
Group
Value
95% CI
Bilateral M1, Active tDCS
1.5
± 1.4
SMA, Active tDCS
1.6
± 1.7
Sham tDCS
1.5
± 1.7
Drops out of view- Session 3
Group
Value
95% CI
Bilateral M1, Active tDCS
1.2
± 1.2
SMA, Active tDCS
1.8
± 1.3
Sham tDCS
1.3
± 1.7
Drops out of view- Session 4
Group
Value
95% CI
Bilateral M1, Active tDCS
1.7
± 2.0
SMA, Active tDCS
0.8
± 0.9
Sham tDCS
1.2
± 1.3
Drops out of view- Session 5
Group
Value
95% CI
Bilateral M1, Active tDCS
1.3
± 1.4
SMA, Active tDCS
1.8
± 1.9
Sham tDCS
1.7
± 0.7
Drops out of view- Session 6
Group
Value
95% CI
Bilateral M1, Active tDCS
1.0
± 1.1
SMA, Active tDCS
1.2
± 1.4
Sham tDCS
1.0
± 1.7
Improper Transfers- Session 1
Group
Value
95% CI
Bilateral M1, Active tDCS
3.8
± 12.9
SMA, Active tDCS
3.1
± 6.6
Sham tDCS
2.2
± 3.3
Improper Transfers- Session 2
Group
Value
95% CI
Bilateral M1, Active tDCS
4.8
± 14
SMA, Active tDCS
1.5
± 2.4
Sham tDCS
1.2
± 2.2
Adverse events — posted to ClinicalTrials.gov
Time frame: 7 days.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
The purpose of this study is to test the influences of transcranial direct current stimulation (tDCS) on the acquisition of laparoscopic surgical skills. For this purpose, the investigator will compare variants of tDCS in the first of 2 experiments. The second arm of the trial will investigate gaze training in a similar study design. These questions will be evaluated using the validated Fundamentals of Laparoscopic Surgery (FLS) module 1, with the overall goal of developing a surgical training curriculum that achieves expert level skill in an expedited timeframe. This research provides a novel approach to general surgery training that has the potential to reduce the amount of time and repetitions required to achieve expert laparoscopic skills.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other trials of transcranial direct current stimulation (tDCS)
Trials testing the same drug.
NCT07535788 — Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting
· not yet recruiting
NCT07458503 — tDCS Combined With Constraint-Induced Therapy in Post-Stroke Upper Limb Rehabilitation
· NA
· not yet recruiting
NCT07500064 — Transcranial Direct Current Stimulation for Depression
· NA
· not yet recruiting
NCT07228468 — Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)
· NA
· recruiting
NCT06883266 — Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
· NA
· recruiting
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise
· NA
· recruiting
NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva
· Phase 1
· recruiting
NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
· Phase 1
· recruiting
NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity
· Phase 1
· recruiting
NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants
· Phase 1
· recruiting
Other Duke University trials
Trials by the same sponsor.
NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation
· NA
· not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment
· NA
· not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
· Phase 1
· not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
· NA
· not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 6 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03083483.